Assessment of Alkasite Restorative Material Versus Resin Modified Glass Ionomer in Class V Cavities: a Clinical Trial
Launched by CAIRO UNIVERSITY · Nov 2, 2024
Trial Information
Current as of September 01, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at two types of materials used to fill cavities (also known as restorations) in the front teeth. Specifically, it will compare a new material called alkasite against a commonly used material known as resin modified glass ionomer. The goal is to see how well each material works over a year for patients who have certain types of cavities in their upper front teeth.
To participate in this study, individuals need to be between 30 and 40 years old and have specific types of cavities classified as Class V (which means they are located at the gum line). It's important that participants are healthy enough to take part and can understand and agree to the study. Throughout the year, participants will receive careful monitoring to assess how well the fillings hold up. This trial will help determine if the new alkasite material is as effective as the resin modified glass ionomer in treating these types of cavities.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • • Adults (30-40Ys) with class V cavities (ICDAS 4 or 5) in upper anterior teeth.
- • Males or females.
- • Have sufficient cognitive ability to understand consent procedures.
- • Co-operative patients approving to participate in the trial.
- • Anterior tooth cervical carious lesion with ICDAS score 4 or 5.
- • Vital upper anterior teeth with no signs or symptoms of irreversible pulpitis.
- • Mobility grade: no clinical mobility.
- • Teeth with healthy periodontium.
- Exclusion Criteria:
- • • Disabilities.
- • Systemic diseases or severe medically compromised.
- • Lack of compliance.
- • Evidence of severe bruxism, clenching or temporomandibular joint disorders.
- • Cognitive impairment
- • Periapical pathosis or signs of pulpal pathology.
- • Non-vital tooth.
- • Signs of pathological wear.
- • Endodontically treated tooth.
- • Severe periodontal affection or tooth indicated for extraction.
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported